Common Stock and Stockholders' Equity (Tables)

3 Months Ended

Jun. 30, 2019

Equity [Abstract]

Schedule of Stock Option and RSU Award Activities

The following table summarizes the Company’s stock option and RSU award activities for the three months ended June 30, 2019 (in thousands, except exercise price, contractual term and fair value information):

	Options Outstanding							RSUs Outstanding
	Number of Shares		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value		Number of Shares		Weighted- Average Grant Date Fair Value		Weighted- Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value
Outstanding - April 1, 2019	2,751		$	35.10	6.3	$	176,002	2,419		$	76.34	3.0	$	238,734
Stock options granted	220		100.25
RSUs granted								279		99.67
Stock options exercised	(84	)	26.90			5,969
RSUs vested								(205	)	54.11
Stock options canceled/forfeited	(26	)	72.89
RSUs canceled/forfeited								(119	)	73.25
Outstanding - June 30, 2019	2,861		$	40.00	6.3	$	141,440	2,374		$	81.16	2.8	$	205,381

Schedule of Stock-based Compensation Expense Attributed to Cost of Revenue, Research and Development, Sales and Marketing and General and Administrative Expenses

Cost of revenue, research and development, sales and marketing, and general and administrative expenses were as follows (in thousands):

	Three Months Ended June 30,
	2019		2018
Cost of revenue	$	1,222	$	693
Research and development	7,028		3,263
Sales and marketing	9,059		4,790
General and administrative	3,879		2,281
Total stock-based compensation expense	$	21,188	$	11,027